Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Orange you glad you ate that? study tests fruit against fatty liver

NCT ID NCT05558592

First seen Apr 04, 2026 · Last updated Jun 22, 2026 · Updated 11 times

Summary

This study looked at whether eating 400 grams of fresh oranges daily for a month could improve metabolism in 60 adults with metabolic-associated fatty liver disease (MAFLD). Participants either ate oranges or other fruits. Researchers measured changes in liver fat and blood fats. The goal was to see if oranges could help control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • IRCCS Saverio de Bellis

    Castellana Grotte, BARI, 70013, Italy

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

oranges (Navelina variety)

What this could lead to

If it works, this could point toward a simple dietary addition to help manage fatty liver disease and reduce metabolic risk.

What could go wrong

This is a small, completed study with only 60 participants. The results may not apply to everyone, and dietary changes alone may not be enough for significant improvement.

Conditions

The condition(s) this trial relates to.

metabolic disease metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.